;

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Health (HESA)

42nd Parliament, 1st Session

Meeting No. 74

Thursday, October 19, 2017, 3:32 p.m. to 5:30 p.m.

Room 253-D, Centre Block

Presiding

Bill Casey, Chair (Liberal)

Expand All Collapse All

Members of the Committee present

Liberal

Conservative

NDP

Don Davies

Acting Members present

• Colin Fraser for Ramez Ayoub (Liberal)

• Marc Serré for Sonia Sidhu (Liberal)

In attendance

Library of Parliament

• Karin Phillips, Analyst

• Marlisa Tiedemann, Analyst

Development of a National Pharmacare Program

Witnesses

As individuals

• Dr. Marc-André Gagnon, Associate Professor, School of Public Policy and Administration, Carleton University

• Prof. Steven Morgan, Professor, School of Population and Public Health, University of British Columbia

Canadian Doctors for Medicare

• Dr. Danyaal Raza, Chair

Canadian Life and Health Insurance Association

• Stephen Frank, President and Chief Executive Officer

• Karen Voin, Vice-President, Group Benefits and Anti-Fraud

Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Monday, March 7, 2016, the Committee resumed its study of the development of a national pharmacare program.

Dr. Marc-André Gagnon, Prof. Steven Morgan, Dr. Danyaal Raza and Stephen Frank made statements and answered questions.

At 5:14 p.m., by unanimous consent and pursuant to Standing Order 115(5), it was agreed that the Committee continue to sit and have another round of three-minute questions.

Committee Business

The Committee proceeded to the consideration of matters related to Committee business.

It was agreed, — That, in relation to the study of antimicrobial resistance, the Committee dedicate the meetings of Thursday, November 2, Tuesday, November 7 and Thursday, November 9, 2017, to hear witnesses.